0 of 7 Questions completed
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
0 of 7 Questions answered correctly
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
You must score 0% to continue. Please click the link below to re-take the quiz
1. What is your degree?
2. What is your specialty?
3. How confident are you in the management of patients with atopic dermatitis in your practice?
4. Differences in genetics and immune dysregulation, which may contribute to disease heterogeneity between children and adults with atopic dermatitis, include which of the following?
5. Which of the following therapies was shown in a recent clinical trial to decrease the weekly average daily worst scratch/itch NRS score for children aged ≥6 months to <6 years with moderate-to-severe AD?
6. Which non-steroidal, phosphodiesterase 4 (PDE4) inhibitor demonstrated success in Investigator’s Static Global Assessment (ISGA) score and improvement in pruritus earlier versus vehicle in two recent phase III atopic dermatitis study?
7. Sarah, an 8-year-old girl with a history of atopic dermatitis since 4 months of age, presents with scaly plaques on face and arms, constant scratching, and seasonal flares during late fall. Her therapeutic history includes treatment with topical steroids, wet wraps, and 1-year course of methotrexate. Based on patient age, history, and presentation, which therapeutic option should be recommended?